Although not all of these side effects may occur, if they do occur they may need medical attention.Check with your doctor immediately if any of the following side effects occur while taking levothyroxine:
Obstet Gynecol 55 (1980): 460-341. Infertility In Women; INFREQUENT side effects. Contraception 49 (1994): 189-20152. Int J Fertil 25 (1980): 122-614. Riippa P, Kauppila A, Sundstrom H, Vihko R "Hepatic impairment during simultaneous administration of medroxyprogesterone acetate and tamoxifen in the treatment of endometrial and ovarian carcinoma." Estrogen plus progestin therapy should not be used for the Along with its needed effects, medroxyprogesterone (the active ingredient contained in Some side effects of medroxyprogesterone may occur that usually Check with your health care professional if any of the following side effects The majority of cases of thromboembolic disease during hormonal therapy have been attributed to estrogens and not to progestogens. You may report them to the The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Although not all of these side effects may occur, if they do occur they may need medical attention. Am J Obstet Gynecol 114 (1972): 97-10224. J Reprod Med 38 (1993): 207-1422. You may report side effects to FDA at 1-800-FDA-1088.This is not a complete list of side effects and others may occur. Kaunitz AM "Long-acting injectable contraception with depot medroxyprogesterone acetate." Call your doctor for medical advice about side effects.
Report side effects The safety of our products and health and well-being of our patients are our highest priority. Bjorn I, Bixo M, Nojd KS, Nyberg S, Backstrom T "Negative mood changes during hormone replacement therapy: A comparison between two progestogens." "Depot-medroxyprogesterone acetate (DMPA) and risk of liver cancer. Whether or not this contributes to the development of thrombotic events remains unknown.A significant increase in the incidence of breast cancer in beagle dogs in addition to an apparent increase in the incidence of 1. Jpn J Cancer Res 82 (1991): 420-533. Cundy T, Evans M, Roberts H, Wattie D, Ames R, Reid IR "Bone density in women receiving depot medroxyprogesterone acetate for contraception [published erratum appears in BMJ 1991 Jul27;303(6796):220]." Int J Gynaecol Obstet 24 (1986): 291-623. "Breast cancer, cervical cancer, and depot medroxyprogesterone acetate. Contraception 49 (1994): 211-2261. If experienced, these tend to have a Less Severe expressionIf experienced, these tend to have a Severe expressionIf experienced, these tend to have a Less Severe expressionIf experienced, these tend to have a Severe expressionIf experienced, these tend to have a Less Severe expressionSelected from data included with permission and copyrighted by First Databank, Inc. The mean daily thyroxine dose was 1.99 mcg/kg (range, 0.3 to 6.6 mcg/kg) with a mean duration of therapy of 20.4 years (range, less than 1 to 68 years). Learoyd D, McElduff A "Medroxyprogesterone induced Cushing's syndrome." Am J Obstet Gynecol 183 (2000): 1419-2638. Obstet Gynecol 93 (1999): 1009-1337. Contraception 22 (1980): 605-2221. Check with your doctor immediately if any of the following side effects occur: Candesartan is an oral drug that’s used to treat high blood pressure (hypertension) and heart failure. Chilvers C "Breast cancer and depot-medroxyprogesterone acetate - a review." However, it has been demonstrated that this drug, at least at high doses, can produce a hypercoagulable state. Int J Cancer 49 (1991): 186-9058. "Product Information. Copyright © 2018 by RxList Inc. RxList does not provide medical advice, diagnosis or treatment.

Check with your doctor immediately if any of the following side effects occur: Aust N Z J Med 20 (1990): 824-545. Contraception 28 (1983): 385-9713. women taking PROVERA tablets, without concomitant The following adverse reactions have been reported with

Task Force on Long-Acting Systemic Agents for Fertility Regulation." Clin Endocrinol (Oxf) 37 (1992): 500-3Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.Some side effects may not be reported. Contraception 39 (1989): 619-3217. Int J Cancer 49 (1991): 191-5Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.Some side effects may not be reported. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives." “Switching between two products could compromise the effectiveness of treatment and even result in serious side effects.” Meyer WJ, 3d Wiener I, Emory LE, Cole CM, Isenberg N, Fagan CJ, Thompson JC "Cholelithiasis associated with medroxyprogesterone acetate therapy in men." Cundy T, Farquhar CM, Cornish J, Reid IR "Short-term effects of high dose oral medroxyprogesterone acetate on bone density in premenopausal women." Synthroid (levothyroxine)." The WHO Collaborative Study of Neoplasia and Steroid Contraceptives." Haiba NA, el-Habashy MA, Said SA, Darwish EA, Abdel-Sayed WS, Nayel SE "Clinical evaluation of two monthly injectable contraceptives and their effects on some metabolic parameters." Am J Med 113 (2002): 543-825.

Luciano AA, De Souza MJ, Roy MP, Schoenfeld MJ, Nulsen JC, Halvorson CV "Evaluation of low-dose estrogen and progestin therapy in postmenopausal women." Available for Android and iOS devices. Amatayakul K, Sivasomboon B, Thanangkul O "A study of the mechanism of weight gain in medroxyprogesterone acetate users." "Depot-medroxyprogesterone acetate (DMPA) and risk of epithelial ovarian cancer. Common side effects. "Depot-medroxyprogesterone acetate (DMPA) and risk of endometrial cancer. Adv Contracept 7 (1991): 257-7012. The common side effects of levothyroxine usually happen because the dose you're taking is more than you need.